WallStreetZen

NYSE: JNJ
Johnson & Johnson Stock

Overview
ForecastEarningsDividendOwnership
$159.48-2.16 (-1.34%)
Updated Apr 13, 2021
JNJ Price
$159.48
Fair Value Price
N/A
Market Cap
$419.84B
52 Week Low
$133.65
52 Week High
$173.65
P/E
28.53x
P/B
6.63x
P/S
5.02x
PEG
1.13x
Dividend Yield
2.5%
Revenue
$82.58B
Earnings
$14.71B
Gross Margin
65.6%
Operating Margin
20.22%
Profit Margin
17.8%
Debt to Equity
1.76
Operating Cash Flow
$24B
Beta
0.66
Next Earnings
Apr 20, 2021
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Expand Score
High
Medium
Low
47
Industry average

Reasons for this score

JNJ ($159.48) is trading below its intrinsic value of $535.46, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
JNJ is poor value based on its earnings relative to its share price (28.53x), compared to the US market average (19.9x)
Valuation
JNJ is poor value based on its earnings relative to its share price (28.53x), compared to the US Drug Manufacturers - General industry average (8.76x)
Valuation

1 of 13

JNJ News

Valuation

JNJ price to earnings (PE)

For valuing profitable companies with steady earnings
Company
28.53x
Industry
8.76x
Market
19.9x
JNJ is poor value based on its earnings relative to its share price (28.53x), compared to the US market average (19.9x)
Valuation
JNJ is poor value based on its earnings relative to its share price (28.53x), compared to the US Drug Manufacturers - General industry average (8.76x)
Valuation

JNJ price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.63x
Industry
5.12x
Market
-0.01x
JNJ is good value based on its book value relative to its share price (6.63x), compared to the US market average (-0.01x)
Valuation
JNJ is poor value based on its book value relative to its share price (6.63x), compared to the US Drug Manufacturers - General industry average (5.12x)
Valuation

JNJ price to earnings growth (PEG)

For valuing profitable companies with growth potential
JNJ is poor value relative to its rate of earnings growth, measured by PEG ratio (1.13x)
Valuation

JNJ's financial health

Profit margin

Revenue
$22.5B
Net Income
$1.7B
Profit Margin
7.7%
JNJ's Earnings (EBIT) of $16.70B can safely cover interest payments on company debt ($35.27B)
Financials
JNJ's profit margin has decreased (-0.6%) in the last year from (18.4%) to (17.8%)
Financials

Assets to liabilities

Assets
$174.9B
Liabilities
$111.6B
Debt to equity
0.56
JNJ's short-term assets ($51.24B) exceed its short-term liabilities ($42.49B)
Financials
JNJ's long-term liabilities ($69.12B) exceed its short-term assets ($51.24B)
Financials
JNJ's debt has increased relative to shareholder equity (1.76), over the past 5 years ago (0.88)
Financials
JNJ's debt to equity ratio (1.76) is considered high
Financials

Cash flow

Operating
$8.3B
Investing
-$7.9B
Financing
-$5.6B
JNJ's operating cash flow ($23.54B) is sufficient to service the company's debt ($35.27B)
Financials

Johnson & Johnson Stock FAQ

What is Johnson & Johnson's quote symbol?

(NYSE: JNJ) Johnson & Johnson trades on the NYSE under the ticker symbol JNJ. Johnson & Johnson stock quotes can also be displayed as NYSE: JNJ.

What is the 52 week high and low for Johnson & Johnson (NYSE: JNJ)?

(NYSE: JNJ) Johnson & Johnson's 52-week high was $173.65, and its 52-week low was $133.65. It is currently -8.16% from its 52-week high and 19.33% from its 52-week low.

How much is Johnson & Johnson stock worth today?

(NYSE: JNJ) Johnson & Johnson currently has 2,632,542,672 outstanding shares. With Johnson & Johnson stock trading at $159.48 per share, the total value of Johnson & Johnson stock (market capitalization) is $419.84B.

Johnson & Johnson stock was originally listed at a price of $32.94 in Dec 31, 1997. If you had invested in Johnson & Johnson stock at $32.94, your return over the last 23 years would have been 384.15%, for an annualized return of 7.1%.

How much is Johnson & Johnson's stock price per share?

(NYSE: JNJ) Johnson & Johnson stock price per share is $159.48 today (as of Apr 13, 2021).

What is Johnson & Johnson's Market Cap?

(NYSE: JNJ) Johnson & Johnson's market cap is $419.84B, as of Apr 15, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Johnson & Johnson's market cap is calculated by multiplying JNJ's current stock price of $159.48 by JNJ's total outstanding shares of 2,632,542,672.
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.